Shout out to two thirds of the media and comms team at @P4AD_ who work tirelessly behind the scenes to make sure patient voices are represented in the media in the fight to lower drug prices! ✊
BIG NEWS: @POTUS just signed the Inflation Reduction Act into law! Thank you Mr. President for your leadership to lower drug prices. This is an incredible win for patients nationwide.
The Senate has passed the Inflation Reduction Act including historic reforms to lower drug prices for millions of Americans! This would not have been possible without tireless advocacy from hundreds of thousands of patients. Read our statement ↓ https://t.co/og7vISCnyn
The Inflation Reduction Act is headed to the Senate! 👏 We agree with Leader Schumer: “This is a major victory for the American people.” We can’t wait to pass these historic drug pricing reforms and deliver relief to patients. https://t.co/cB4pnOwsnH
Year after year for most of two decades, proposals to allow the government to negotiate lower prices from drug companies for Medicare recipients have wound up dead in Congress.
Now the Washington drug lobby is on the cusp of a rare political loss. https://t.co/b5meTw5fUd
No one should have to ration lifesaving medication. Today I joined patients, @P4ADNOW, and @AARP to talk about the work I’ve been doing to lower prescription drug costs, save Nevadans money at the pharmacy, and keep our seniors healthy.
Now is the time to lower drug prices and help so many people – from seniors who worry about the cost of their prescriptions to diabetics who rely on insulin. @SenCortezMasto, @JoAnn_Jenkins, @P4AD & I came together to make it clear: we will not back down.
Check out @DavidP4AD in the @nytimes: "We can — and should — bring down monopoly prices by empowering Medicare to negotiate, but we must also reform our patent system to address the drivers that lead to unjustified monopolies in the first place."
https://t.co/alH0QMiAM6
NEW: @TheHillOpinion piece by @RepSusanWild and @DavidP4AD calls on the Senate to enact historic and comprehensive drug pricing reforms that bring relief to all patients and save money for consumers and taxpayers.⬇️ https://t.co/3Rbd6ZCbrf
Our third drug pricing forum is happening in just a couple of weeks! Join Rose Keller, a young adult cystic fibrosis patient, and @audreybakerm from @P4AD_ as we talk about how YOU can get involved in drug pricing! Register below!
https://t.co/5xSlNDdb6B
I’m determined to pass my Build Back Better Act and ensure Sa’Ra – and millions others – don’t pay more than $35 a month for insulin. As I told her: Keep the faith. We’re going to get this done.
Big news: The M+R union just ratified our 2nd contract 📢 And it's really good one! 📢
💯% of our unit voted YES on this contract that reflects our values, and we’re thrilled to share some of the highlights (and how we won them!) 🧵
Introducing Biden’s remarks on prescription drugs, diabetic Iesha Meza calls for reforms to lower the cost of insulin for everyone.
Meza shared her story with The Post in October. https://t.co/be0AP9D54J
Iesha, a patient from Arizona, joined @POTUS to talk about the impact her insulin prices have had on her life. After nearly dying because she was unable to afford her drugs, she has a powerful message — nobody should have to choose between paying rent or affording meds.
Story from @IgorDerysh recounts the history of phrma's backroom deals and influence peddling to keep its economic power over patients and the people of our country. It's not pretty, but it's the real face of phrma. https://t.co/4leXWIJyGV
On behalf of patients, we demand that congressional Democrats reject the Build Back Better framework until it includes the most popular provision: effective Medicare negotiation to lower drug prices for Americans. Full statement: https://t.co/hC5ZHPQZcb
"It's unforgivable."
@RepKathleenRice, @RepScottPeters, @SenatorSinema, and @RepSchrader are doing Big Pharma's bidding and trying to gut the Medicare negotiation plan. Americans WON'T settle for less. We need strong Medicare negotation that will lower prices for patients.